Latest articles for Major Depressive Disorder
Commentary
Let’s not criticize off-label prescribing
It is important to state clearly that off-label prescribing is part and parcel of the good practice of clinical medicine, say Dr. Robert S. Emmons...
Feature
Fauci worries about possible post–COVID-19 ‘mental health pandemic’
“I hope we don’t see an increase in some preventable situations that would not have happened if people had the normal access to medical care,”...
Feature
Meghan Markle interview resurfaces suicidality screening debate
Ask open-ended questions of those patients who are struggling, said Dr. Mona Masood.
Commentary
Meghan Markle disclosures can be used to raise awareness, reduce stigma
Cultures that traditionally emphasize self-sufficiency or stoicism may unintentionally create additional barriers to reaching out for help, said...
Feature
Benefits of bremelanotide to women with HSDD questioned in analysis paper
Author of paper criticized reacts to analysis of bremelanotide data.
From the Journals
Novel therapeutic target for depression identified
Previous research using a chronic social defeat model of depression in mice showed changes in the KCNQ2/3 channel.
Feature
How to make resident mental health care stigma free
Opt-out programs offer a counterbalance to many negative tendencies in residency, said Dr. Lisa Meeks.
Conference Coverage
Fear, stigma can stymie the care of criminal justice-involved outpatients
“As clinicians working with outpatients, we have to understand the whole person, and what might be going on in their lives,” Dr. Debra A. Pinals...
News from the FDA/CDC
U.S. suicide rate in 2019 took first downturn in 14 years
As the response to the COVID-19 pandemic continues, the investigators pointed out, "prevention is more important than ever."
Conference Coverage
Severe atopic dermatitis often puts a dent in quality of life
“There have been many surveys of adults with AD who report impairment of their sleep, reduced activity level, increased work absence, financial...